Source Peptides supplies research compounds exclusively to qualified researchers, research institutions, and laboratories for in-vitro laboratory research only. Access is restricted to U.S. residents 21 years of age or older.
Access to this site is restricted to U.S. residents aged 21 or older.
By proceeding, you certify that the statements above are true and accurate. Our products are for research and investigative purposes only. They are not intended for human consumption, clinical use, or therapeutic application. Nothing on this website is intended to diagnose, treat, cure, or prevent any disease. The safety and efficacy of these products have not been established, and they have not been evaluated or approved by the U.S. Food and Drug Administration (FDA).
NAD+ nasal spray has emerged as one of the most discussed delivery formats in contemporary preclinical research, offering investigators a non-invasive route for studying nicotinamide adenine dinucleotide biology in neurological, metabolic, and cellular aging models. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell and serves as a fundamental substrate for hundreds […]
BPC-157, a synthetic pentadecapeptide derived from a protective gastric protein sequence, has become one of the most studied compounds in preclinical peptide research. Across dozens of published animal model investigations, researchers have systematically varied concentration levels, administration schedules, and delivery routes to better understand how these variables interact with the peptide’s observed biological effects. Understanding […]
The KLOW peptide stack has emerged as a subject of growing interest among laboratory researchers investigating multi-component peptide systems and their distinct mechanistic profiles. Comprising a specific combination of bioactive peptide sequences, KLOW is designed as a research formulation that occupies a different investigative space than the well-characterized GLOW stack — with each component contributing […]
Bacteriostatic water for peptide research represents one of the most foundational yet frequently overlooked variables in laboratory reconstitution workflows. While considerable attention is directed toward the peptide compounds themselves — their sequences, receptor targets, and preclinical findings — the solvent used to reconstitute lyophilized peptides plays a critical and often underappreciated role in determining solution […]
GHK-Cu — glycyl-L-histidyl-L-lysine complexed with copper(II) — is a naturally occurring tripeptide-copper complex that has drawn sustained scientific attention for its unusually broad influence on gene expression, tissue remodeling, and cellular repair pathways in preclinical models. First isolated from human plasma in the early 1970s, it remains one of the most studied endogenous copper-binding peptides […]
PT-141 nasal spray has emerged as the most-searched peptide delivery format in 2026, with researcher interest surging across melanocortin biology, central nervous system signaling, and peptide pharmacokinetics. As a cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (α-MSH), PT-141 — also designated bremelanotide in the scientific literature — engages melanocortin receptors with a mechanistic profile that distinguishes […]
GHK-Cu — the copper-binding tripeptide glycine-histidine-lysine — has emerged as one of the most extensively studied naturally occurring peptide-metal complexes in modern biochemical research. First isolated from human plasma in the early 1970s by Loren Pickart, GHK-Cu has since accumulated a substantial body of preclinical literature examining its roles in tissue remodeling, gene expression modulation, […]
CJC-1295 with DAC nasal spray has emerged as a focal point of delivery-format research among scientists investigating growth hormone-releasing hormone (GHRH) analogue biology. The addition of a Drug Affinity Complex (DAC) to the CJC-1295 backbone fundamentally alters the peptide’s pharmacokinetic profile by enabling albumin binding — a mechanism that has been studied extensively in preclinical […]
First synthesized in the Soviet Union as a derivative of adrenocorticotropic hormone, Semax has quietly accumulated one of the most intriguing preclinical research dossiers of any synthetic neuropeptide — spanning neurotrophin upregulation, cerebrovascular models, and cognitive task performance in rodents. This guide consolidates everything the scientific literature currently reveals about Semax, strictly in the context […]
PT-141, also known by its systematic name bremelanotide, is a synthetic cyclic heptapeptide that has attracted sustained preclinical research interest for its interactions with the melanocortin receptor system — particularly MC3R and MC4R subtypes in the central nervous system. Unlike many peptides studied for peripheral tissue effects, PT-141 research is distinguished by its CNS-centric mechanism, […]
